Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
Triple-negative breast cancer (TNBC) is considered one of the un-manageable types of breast cancer, involving devoid of estrogen, progesterone, and human epidermal growth factor receptor 2 (HER 2) receptors. Due to their ability of recurrence and metastasis, the management of TNBC remains a mainstay...
Main Authors: | Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, Sanjay Singh, Pradeep Kumar, Pradeep Kumar Bolla, Dinesh Kumar, Ashish Kumar Agrawal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/5/542 |
Similar Items
-
Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
by: Aiswarya Chaudhuri, et al.
Published: (2023-05-01) -
Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy
by: Aiswarya Chaudhuri, et al.
Published: (2022-09-01) -
Transcriptional landscape associated with TNBC resistance to neoadjuvant chemotherapy revealed by single-cell RNA-seq
by: Radhakrishnan Vishnubalaji, et al.
Published: (2021-12-01) -
Unrevealing the Role of miRNA in Successful TNBC Treatment: A Pilot Study to Explore the Chemotherapy Drugs for Timely Treatment of TNBC
by: Poulami Sarkar, et al. -
Editorial: Targeting triple negative breast cancer by natural compounds
by: Shashank Kumar, et al.
Published: (2023-03-01)